SecBot SecBot
8-K ·Filed Jun 16, 2026

LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.
BULLISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0001493152-26-028878
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▲ Bullish

Monitor closing conditions, particularly the $16.5M cash condition (likely satisfied by the June 4 offering) and Nasdaq listing approval for the Exchange Common Shares. Post-closing, the key catalyst is the stockholder meeting (within 60 days) to approve Series D Preferred conversion — failure to obtain approval would leave the preferred non-convertible and non-voting, capping upside. The massive potential dilution overhang (~330% if fully converted) may cap near-term gains until conversion mechanics are clarified. Watch for the resale registration statement filing within 30 days after stockholder approval, which could enable selling by NOMAD stockholders.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+5d
LIXT ▼ -1.29% at T+5d
LONG call ✗ call lost -1.29% · α vs SPY -0.25% · entry $6.96 → $6.87
Next anchor: T+20d due 3mo ago
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
+9.34%
call +9.34% · α +8.56%
$7.61
settled 4mo ago
T+5d
-1.29%
call -1.29% · α -0.25%
$6.87
settled 4mo ago
T+20d
Pending
due 3mo ago
T+60d
Pending
due 7w ago

Price Chart

Loading chart...

Executive Summary

LIXTE Biotechnology Holdings (LIXT) entered into a definitive merger agreement to acquire 100% of NOMAD Transportable Power Systems, a market leader in mobile utility-grade battery energy storage systems (BESS), via a reverse merger. The transaction transforms LIXT from a clinical-stage biotech into a growth-stage energy infrastructure company, with NOMAD reporting ~175% YoY revenue growth in 2025 and projecting ~135% growth in 2026. The deal is financed in part by a recent $16.6M registered direct offering (filed June 4, 2026) that satisfies the $16.5M closing cash condition, and LIXT will be renamed NOMAD Power Solutions upon closing.

Key Financial Metrics

Deal Type
merger

Key Facts

  • LIXT to acquire NOMAD via reverse merger; NOMAD survives as wholly-owned subsidiary
  • Consideration: up to 50,500 Series D Convertible Preferred shares (original issue price $1,000/share, convertible into 50.5M common shares at $1.00/share) and up to 3,000,000 shares of LIXT common stock
  • NOMAD revenue grew ~175% YoY in 2025, with management projecting ~135% YoY growth in 2026
  • Closing requires LIXT to have at least $16.5M unrestricted cash; recent $16.6M offering (June 4, 2026) appears to satisfy this condition
  • Post-closing, LIXT must hold a stockholder meeting within 60 days to approve conversion of Series D Preferred, increase authorized shares, and elect directors
  • LIXT had 15,292,339 shares outstanding as of June 11, 2026; potential full conversion of Series D Preferred would add up to 50.5M shares (~330% dilution if fully converted)
  • NOMAD has 29,741,876 shares outstanding, plus options (323,000), RSUs (6,412,800), and warrants (25,516,800) that will be settled for common stock pre-closing
  • LIXT to be renamed NOMAD Power Solutions; ticker symbol to change
  • John Travaglini (NOMAD CEO) to join LIXT board and become CEO of surviving subsidiary
  • Resale registration statement for Exchange Shares to be filed within 30 days after stockholder approval of conversion

Financial Impact

Transformative acquisition pivoting LIXT from pre-revenue biotech to growth-stage energy storage. NOMAD's revenue growth rates cited (~175% YoY in 2025, ~135% projected in 2026) but no absolute dollar figures disclosed. Consideration is stock-based with no stated total deal value. The Series D Preferred has a $1,000/share original issue price, implying a $50.5M notional value for the preferred component at maximum issuance, plus 3M common shares at an undetermined price.

revenuedilutionenterprise valuebusiness model

Risk Factors

  • Failure to obtain stockholder approval for Series D Preferred conversion at the post-closing meeting
  • Nasdaq listing approval for Exchange Common Shares not obtained
  • Massive potential dilution (~330% if all Series D Preferred converted) could pressure common stock
  • Integration risk and execution of NOMAD's aggressive growth projections (~135% YoY in 2026)
  • LIXT's existing biotech operations (LB-100, Liora Technologies) may be de-emphasized or divested
  • Reverse merger structure carries higher execution risk than traditional acquisition

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028878
Exhibit: ex99-1.htm0001493152-26-028878
Document: form8-k.htm0001493152-26-028878
Document: 0001493152-26-028878-index-headers.html0001493152-26-028878
Document: 0001493152-26-028878-index.html0001493152-26-028878
Document: 0001493152-26-028878.txt0001493152-26-028878
10 reports for LIXT
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +22.94%Jun 12, 2026
Filters
Rows
Reports for LIXT — sortable, filterable
TypeNow
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$7.29awaiting T+1——
Jun 18, 2026
18w ago
8-K
BULLISH ★ 6/10
$7.48 $7.30▼ −2.41%▼ −0.95%—
Jun 16, 2026
18w ago
8-K
BULLISH ★ 7/10
$6.96 $7.61▲ +9.34%▲ +8.56%—
Jun 12, 2026
19w ago
Press Release
BULLISH ★ 7/10
$6.19 $6.72▲ +8.56%▲ +6.80%—
Jun 4, 2026
20w ago
8-K
BEARISH ★ 6/10
$7.00 $6.65▲ +5.00%▲ +5.23%—
Jun 4, 2026
20w ago
424B5
BEARISH ★ 6/10
$7.00 $6.65▲ +5.00%▲ +5.23%—
Jun 1, 2026
21w ago
8-K
BULLISH ★ 6/10
$7.21 $7.04▼ −2.36%▼ −2.50%—
May 14, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$5.16 $4.70▼ −8.91%▼ −8.85%—
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$3.44 $3.48▲ +1.16%▲ +1.82%—
Apr 13, 2026
28w ago
Press Release
NEUTRAL ★ 5/10
$2.93 $2.91▼ −0.68%▼ −1.89%—
Showing 10 of 10

US Market Status

Market Open — Closes in 3h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026